I now have comprehensive information on DKA pathogenesis, clinical features, diagnosis, and management. Let me compile a thorough, well-structured answer.
Diabetic Ketoacidosis (DKA)
1. Pathogenesis
Core Hormonal Mechanism
DKA results from the combined effects of absolute or relative insulin deficiency plus excess counter-regulatory hormones (glucagon, cortisol, catecholamines, growth hormone). This hormonal imbalance drives three parallel metabolic catastrophes:
a) Hyperglycemia pathway
- Insulin deficiency impairs glucose uptake into cells
- Glucagon excess stimulates hepatic glycogenolysis and gluconeogenesis
- Substrates delivered to the liver include amino acids and lactate from muscle, and free fatty acids/glycerol from adipose tissue
- Glucose is produced and released faster than it is used
b) Ketogenesis pathway
- Insulin deficiency activates hormone-sensitive lipase in adipose tissue
- Long-chain free fatty acids (FFAs) are released into circulation in abundance
- In the liver, FFAs are partially oxidized and converted to ketone bodies: acetoacetate, β-hydroxybutyrate, and acetone
- The ratio of β-hydroxybutyrate to acetoacetate rises significantly in established DKA (explains why nitroprusside-based dipstick tests can underestimate ketosis - they only detect acetoacetate)
- Ketones accumulate faster than peripheral tissues can utilize them, causing ketonemia and ketonuria
c) Osmotic diuresis and electrolyte depletion
- Hyperglycemia exceeds the renal threshold, causing glycosuria
- Glucose in renal tubules draws water, sodium, potassium, magnesium, calcium, and phosphorus into the urine
- This osmotic diuresis, combined with poor intake and vomiting, causes profound dehydration and electrolyte loss
- Average deficits in severe DKA: fluid 70-120 mL/kg, Na 8-10 mEq/kg, K 5-7 mEq/kg
Important electrolyte paradox: Despite total-body deficits, initial serum potassium, magnesium, and phosphorus are often normal or elevated because acidosis shifts these ions from intracellular to extracellular compartments. As insulin is given and acidosis corrects, these electrolytes shift back intracellularly and serum levels fall rapidly - creating a risk of life-threatening hypokalemia.
d) Metabolic acidosis
- Accumulating ketoacids consume bicarbonate, producing a high anion gap metabolic acidosis
- The body compensates with Kussmaul breathing (deep, rapid respirations) to exhale CO₂
- Severe acidosis worsens insulin resistance and depresses mental status directly
- Cerebrospinal fluid pH falls more slowly than blood pH, so bicarbonate administration can paradoxically worsen CNS acidosis
Common Precipitants
| Most Common | Other Precipitants |
|---|
| Infections | Acute pancreatitis |
| Nonadherence with insulin | Stroke, pulmonary embolism |
| New-onset type 1 diabetes | Acute MI |
| Unknown | SGLT-2 inhibitors (euglycemic DKA) |
| Corticosteroids, clozapine, cocaine |
| Thyrotoxicosis, Cushing syndrome |
~25% of DKA episodes occur in patients with previously undiagnosed diabetes.
2. Clinical Features
Symptoms (Hours to Days of Deterioration)
- Polyuria, polydipsia, polyphagia - classic osmotic symptoms
- Nausea, vomiting - very common; may cause or worsen dehydration
- Abdominal pain - present in ~50% of patients (especially children); usually resolves with metabolic correction. In adults, pain should raise suspicion for a real abdominal precipitant (e.g., pancreatitis, appendicitis)
- Weakness, weight loss, anorexia
- Visual blurring
- Lethargy progressing to altered consciousness or frank coma in severe cases
Signs
| Finding | Mechanism |
|---|
| Kussmaul breathing (deep, rapid respirations) | Respiratory compensation for metabolic acidosis |
| Fruity/acetone odor on breath | Acetone exhalation |
| Tachycardia | Dehydration, compensatory |
| Hypotension (frank or orthostatic) | Volume depletion |
| Dry skin and mucous membranes | Dehydration |
| Reduced JVP, skin turgor loss | Volume depletion |
| Depressed sensorium / coma | Hyperosmolality, acidosis |
| Fever | Almost always indicates underlying infection (not DKA itself) |
Key Laboratory Findings
| Parameter | DKA | HHS (for comparison) |
|---|
| Glucose (mg/dL) | >350 (euglycemic DKA possible with SGLT-2i) | >700 |
| pH | <7.3 (severe <7.0) | >7.3 |
| Bicarbonate (mmol/L) | <18 (severe <10) | >18 |
| Serum ketones | 2+ or ≥3.0 mmol/L | Absent/trace |
| Anion gap | Elevated (proportional to HCO₃ fall) | Normal |
| Sodium | Low (corrected = reported Na + 1.6 per 100 mg/dL glucose above normal) | Normal/high |
| Potassium | Normal or high initially (but total body depleted) | ~Normal |
| WBC | Elevated (reflects ketosis degree, not necessarily infection; only bandemia reliably indicates infection) | |
DKA severity classification (Goldman-Cecil):
- Mild: pH 7.20-7.30, HCO₃ 15-18, anion gap >10
- Moderate: pH 7.10-7.19, HCO₃ 10-14
- Severe: pH <7.10, HCO₃ <10
3. Management
Step 1: Stabilize and Assess Airway
- Avoid intubation if possible - patients have tremendous respiratory drive and matching ventilator settings is difficult
- Intubate if comatose, especially if vomiting (aspiration risk)
- Hypovolemic shock: aggressive isotonic crystalloid before vasopressors
Step 2: Intravenous Fluids (Most Important Initial Step)
- First 1-3 hours: 1-2 L of 0.9% normal saline (NS)
- Children: 20 mL/kg NS in first hour
- This alone can lower glucose ~18% by improving renal perfusion and transporting residual insulin
- Improves acidosis by restoring tissue perfusion and reducing lactate production
- After initial resuscitation: switch to 0.45% NS to continue correcting free water deficit
- Target urine output: 1-2 mL/kg/hour
Note: Some evidence supports balanced crystalloids (Plasmalyte) to reduce risk of hyperchloremic acidosis from large NS volumes.
Step 3: Insulin
- Do NOT start insulin until K⁺ ≥ 3.3 mEq/L (risk of fatal hypokalemia)
- Start regular insulin IV infusion at 0.1 units/kg/hour (fixed rate)
- Once glucose falls to ≤250-300 mg/dL:
- Switch IV fluid to D5W / 0.45% NS to allow continued insulin infusion without causing hypoglycemia
- Reduce insulin to 0.05 units/kg/hour to prevent hypoglycemia and hypokalemia
- Continue insulin until ketosis is resolved (ketones <1.0 mmol/L, pH normalized, anion gap closed) - do not rely on glucose normalization alone
Transition to subcutaneous insulin:
- Once patient is eating and ketoacidosis resolved, restart usual SC insulin regimen
- Maintain 1-2 hour overlap between SC dose and stopping IV infusion to prevent rebound ketosis
Recent meta-analyses (PMIDs 39090718, 41208563) show subcutaneous insulin protocols are non-inferior to IV infusion for selected mild-moderate DKA cases, offering potential for step-down unit management.
Step 4: Potassium Replacement
- K⁺ < 3.3 mEq/L: Replace aggressively before starting insulin (20-40 mEq/hr IV); hold insulin
- K⁺ 3.3-5.5 mEq/L: Add 20-40 mEq KCl to each liter of IV fluid
- K⁺ > 5.5 mEq/L: Do not add K; monitor closely; levels will fall with insulin
- Use corrected K formula: subtract 0.6 mEq/L for every 0.1 decrease in pH below normal
- Example: reported K 5.0 mEq/L with pH 6.94 → corrected K ≈ 2.0 mEq/L (severe hypokalemia masked)
Step 5: Bicarbonate - Generally NOT Recommended
- IV fluids and insulin alone are sufficient for most cases
- Risk: paradoxical CNS acidosis; may worsen hypokalemia; delays diagnosis of resolution
- Consider only if: pH < 7.0, not responding to fluids and insulin, with profound acidosis
- Administer as NaHCO₃ 50-100 mEq slowly over 1-2 hours if used
Step 6: Phosphate and Magnesium
- Total body phosphate is depleted but routine IV replacement is NOT recommended
- Replace phosphate only if <1.0 mg/dL with muscle weakness or other complications
- Magnesium: correct with 1-2 g MgSO₄ if deficient (serum levels often don't correlate with body stores)
Step 7: Monitor Progress Closely
Hourly or 2-hourly:
- Serum glucose, K⁺, HCO₃⁻, anion gap
- pH (venous acceptable)
- Fluid input and urine output
- ECG for potassium changes
Step 8: Identify and Treat Precipitating Cause
- Cultures, ECG, chest X-ray
- Treat infection, ACS, pancreatitis, etc.
- Key point: Do not stop insulin during illness in type 1 DM
Resolution Criteria
All three of the following must be met before stopping IV insulin:
- Blood glucose < 200-250 mg/dL
- Serum bicarbonate ≥ 15 mmol/L
- Venous pH > 7.3
Prognosis
Despite aggressive treatment, mortality remains ~4% for DKA and up to 20% for HHS. Mortality is associated with extremes of age, comorbid conditions, and severity of the precipitant.
Sources: Goldman-Cecil Medicine (9780323930345), Rosen's Emergency Medicine (9780323757898)
Recent Evidence:
- Subcutaneous vs IV insulin meta-analysis (PMID 39090718) - found subcutaneous insulin comparable to continuous IV infusion in adults with DKA
- Early SC basal insulin with IV infusion meta-analysis (PMID 41208563) - 2026 RCT meta-analysis supports early addition of SC basal insulin to reduce rebound DKA risk at transition